近日，港股上市药企康哲药业控股有限公司（以下简称“康哲药业”）发布公告称，拟将附属公司德镁医药有限公司（以下简称“德镁医药”）拆分上市。康哲药业的业务主要覆盖心脑血管、消化、皮肤/医美、眼科四大领域。此次将德镁医药拆分上市，是将皮肤医美板块的业务拆分。背靠母公司康哲药业，德镁医药却暗藏隐忧：核心产品均靠外部采购，自主生产能力相对薄弱。此外，2022年至2024年，公司砸下9亿元营销费用进行推广，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.